Table 2.
Occurence of CD3+ and NK1.1+ Cells in PB and Spleen MNC of IL-2Rβ–deficient Mice
| PB | Spleen MNC | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total leukocytes (× 106 ml PB) (n = 3) | CD3+ NK1.1− (Percent, n = 13) | NK1.1+ CD3− | Total MNC (× 106 ml spleen) (n = 3) | CD3+ NK1.1− (Percent, n = 6) | NK1.1+ CD3− | |||||||
| IL-2Rβ+/− | 8.6 ± 0.9 | *33.9 ± 4.4 | *2.3 ± 0.3 | 74.3 ± 5.9 | ‡35.6 ± 4.0 | ‡2.2 ± 0.4 | ||||||
| IL-2Rβ−/− | 2.1 ± 0.5 | 53.2 ± 4.0 | 0.5 ± 0.01 | 24.8 ± 4.6 | 48.5 ± 5.8 | 0.5 ± 0.01 | ||||||
*
Numbers are mean ± SEM percentage of total leukocytes found in each quadrant as determined by FACS® analysis.
‡
Numbers are mean ± SEM percentage of total spleen MNC found in each quadrant as determined by FACS® analysis.